Wall Street's major averages plummeted on Friday after Israel and Iran traded missile strikes and stoked concerns of an ...

BioNTech (NASDAQ:BNTX) has agreed to acquire its German rival CureVac (NASDAQ:CVAC) in an all-stock transaction worth nearly ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

Plus: Oracle posts strong quarterly results boosted by the company's artificial-intelligence investments. Biotech company BioNTech acquires CureVac. Adobe raises its full-year outlook after posting ...

The BioNTech SE acquisition of CureVac N.V. brings together complementary technologies, as both are developing mRNA ...

Dow Jones Top Company Headlines at 3 PM ET: Micron Technology to Invest $200 Billion in U.S. Semiconductor Manufacturing | Boeing ... Micron Technology to Invest $200 Billion in U.S. Semiconductor ...

Three years after litigation started over technology used in Comirnaty, the mRNA vaccine for COVID-19, Biontech SE is acquiring its adversary, Curevac NV, through an all-stock transaction valued at ...

Key Takeaways U.S. equities were mixed and little changed at midday as a second inflation report this week came in lower than ...

Biotech stock CureVac NV (NASDAQ:CVAC) was last seen up 32.2% at $5.37, after news that BioNTech (BNTX) is acquiring the company in all-stock deal worth $1.25 billion. The merger is still awaiting ...

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two ...

Halper Sadeh encourages CureVac shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or ...